We are live on ! Find out more
BSX icon

Boston Scientific

556 hedge funds and large institutions have $27.2B invested in Boston Scientific in 2016 Q4 according to their latest regulatory filings, with 75 funds opening new positions, 184 increasing their positions, 223 reducing their positions, and 75 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more call options, than puts

Call options by funds: $78.3M | Put options by funds: $57.4M

0.49% more ownership

Funds ownership: 91.82%92.31% (+0.49%)

0% more first-time investments, than exits

New positions opened: 75 | Existing positions closed: 75

2% less funds holding

Funds holding: 565556 (-9)

7% less capital invested

Capital invested by funds: $29.4B → $27.2B (-$2.18B)

17% less repeat investments, than reductions

Existing positions increased: 184 | Existing positions reduced: 223

44% less funds holding in top 10

Funds holding in top 10: 169 (-7)

Holders
556
Holders Change
-9
Holders Change %
-1.59%
% of All Funds
13.9%
Holding in Top 10
9
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-43.75%
% of All Funds
0.23%
New
75
Increased
184
Reduced
223
Closed
75
Calls
$78.3M
Puts
$57.4M
Net Calls
+$20.9M
Net Calls Change
-$14.7M
Name Holding Trade Value Shares
Change
Change in
Stake
AAM
376
Azzad Asset Management
Virginia
$602K +$13.4K +616 +2%
TMAM
377
Tokio Marine Asset Management
Japan
$599K -$221K -10,124 -27%
EVM
378
Eaton Vance Management
Massachusetts
$578K -$37M -1,698,025 -98%
SSA
379
Schonfeld Strategic Advisors
New York
$576K -$656K -30,083 -53%
AP
380
AHL Partners
United Kingdom
$538K -$496K -22,744 -48%
EP
381
Edgestream Partners
New Jersey
$534K -$592K -27,146 -52%
KeyBank National Association
382
KeyBank National Association
Ohio
$534K -$29.2K -1,336 -5%
OC
383
Oppenheimer & Co
New York
$525K +$284K +13,038 +116%
MIP
384
Marietta Investment Partners
Wisconsin
$523K -$6.47M -296,615 -92%
UCFA
385
United Capital Financial Advisors
Texas
$521K -$836K -38,295 -61%
CAM
386
ClariVest Asset Management
California
$518K +$106K +4,863 +25%
W
387
Wealthfront
California
$513K +$33K +1,513 +7%
IIM
388
Intact Investment Management
Quebec, Canada
$504K +$292K +13,400 +135%
LCM
389
Laurion Capital Management
New York
$502K +$506K +23,200 New
BCM
390
BlueCrest Capital Management
Jersey
$497K +$27.2K +1,248 +6%
BHA
391
Beech Hill Advisors
New York
$489K -$43.6K -2,000 -8%
CA
392
Commerzbank Aktiengesellschaft
Germany
$488K +$124K +5,700 +34%
CLOS
393
Compagnie Lombard Odier SCmA
Switzerland
$487K -$109K -5,000 -18%
Pacer Advisors
394
Pacer Advisors
Pennsylvania
$485K -$2.92K -134 -0.6%
BAAM
395
Baker Avenue Asset Management
California
$485K +$48.4K +2,220 +11%
BC
396
Banced Corp
Illinois
$482K +$14.6K +671 +3%
RCAMU
397
Rothschild & Co Asset Management US
Connecticut
$459K +$67.8K +3,106 +17%
RCA
398
Rowland Carmichael Advisors
Arizona
$454K
LOAME
399
Lombard Odier Asset Management (Europe)
United Kingdom
$453K
FAAS
400
First Allied Advisory Services
California
$450K +$454K +20,801 New

BSX Hedge Fund Activity: Q4 2016 in Review

556 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2016, worth a combined $27.2B — down 7.4% from $29.4B a quarter earlier.

Fund positioning in BSX was balanced in Q4 2016: 75 funds opened new positions, 75 closed out, 184 added to existing stakes and 223 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $137M. The largest seller was Wellington Management Group, cutting an estimated $151M.

  • 556 institutional investors held Boston Scientific (BSX) as of Q4 2016, down from 565 in Q3 2016.
  • Funds reported $27.2B of Boston Scientific stock for Q4 2016, down 7.4% quarter-over-quarter.
  • 75 funds opened new Boston Scientific positions in Q4 2016 and 75 closed out, a net change of 0 holders.
  • The largest Boston Scientific buyer in Q4 2016 was Janus Henderson Investors US, an estimated $137M added.
  • The largest Boston Scientific seller in Q4 2016 was Wellington Management Group, an estimated $151M sold.

Based on aggregated 13F filings for Q4 2016.